$16.33
0.311.94%
Últ. Act.: Oct 9, 11:09 AM
$16.01
-0.01-0.06%
NeoGenomics (NEO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
NeoGenomics (NEO) publicó su última previsión de octubre 5, 2026 para Q3 2026. La compañía estimó ingresos en un rango de $209M - $209M para el período.
En comparación con la previsión anterior, NeoGenomics reducido redujo su previsión de ingresos desde un rango anterior de $802M - $806M.
NeoGenomics ha emitido 24 actualizaciones de orientación entre el febrero 23, 2023 y el octubre 5, 2026. During this period, the company raised its outlook 9 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.01 | $-0.02 | $0.01 | $-0.01 |
| Actual | $0.05 | $0.01 | $0.06 | $0.03 |
| Surprise | +400.0% | +150.0% | +500.0% | +400.0% |
| Revenue | ||||
| Estimate | $197.0M | $184.5M | $188.4M | $183.8M |
| Actual | $202.0M | $186.7M | $190.2M | $187.8M |
| Surprise | +2.52% | +1.19% | +0.96% | +2.20% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.04 | $0.05 | $-0.01 | $0.03 |
| Revenue | ||||
| Consensus | $207.0M | $209.9M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 28, 2026 | $0.05 | $0.01 | 400.0 % |
| Q1 | Apr 28, 2026 | $0.01 | $-0.02 | 150.0 % |
| Q4 | Feb 17, 2026 | $0.06 | $0.01 | 500.0 % |
| Q3 | Oct 28, 2025 | $0.03 | $-0.01 | 400.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Jul 28, 2026 | $202.00M | $197.04M | 2.52 % |
| Q1 | Apr 28, 2026 | $186.67M | $184.47M | 1.19 % |
| Q4 | Feb 17, 2026 | $190.17M | $188.36M | 0.96 % |
| Q3 | Oct 28, 2025 | $187.80M | $183.76M | 2.20 % |